Pancreatic Cancer Research

ResearcherUniversity of MiamiActive in the last 2 years

Nikita Sharma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3528-1634; OpenAlex author ID A5030291750. Sources: OpenAlex.

Their work

Papers
13 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2017: 2 papers · 2018: 3 papers · 2019: 3 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 13

  1. Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltratio… Co-author DOI 10.1158/2767-9764.crc-25-0460↗
  2. Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model. First author DOI 10.1111/cas.15903↗
  3. Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215591↗
  4. Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-20-2562↗
  5. Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy. Co-author DOI 10.1172/jci127515↗
  6. Targeting tumor intrinsic metabolic node in pancreatic cancer causes tumor regression,remodels extracellular matrix and sensitizes to anti-PD1 therapy Co-author DOI 10.1016/j.pan.2019.05.430↗
  7. ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining "stemness". First author DOI 10.1038/s41419-019-1408-5↗
  8. O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability. Co-author DOI 10.7150/thno.32615↗
  9. GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells. First author DOI 10.1002/1878-0261.12322↗
  10. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity. First author DOI 10.1016/j.canlet.2018.09.028↗
  11. Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression. Co-author DOI 10.1158/0008-5472.can-17-2320↗
  12. Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer. Co-author DOI 10.1038/s41598-017-01696-2↗
  13. Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer. Co-author DOI 10.1038/s41598-017-08447-3↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vineet Kumar Gupta · 11 shared papers, 2017–2022 · strength 1.02
  2. Ashok Kumar Saluja · 11 shared papers, 2017–2022 · strength 1.02
  3. Vikas Dudeja · 10 shared papers, 2017–2022 · strength 0.91
  4. Sulagna Banerjee · 10 shared papers, 2017–2021 · strength 0.87
  5. Bhuwan Giri · 6 shared papers, 2017–2022 · strength 0.57
  6. Patricia Dauer · 7 shared papers, 2017–2019 · strength 0.56
  7. Kousik Kesh · 6 shared papers, 2018–2021 · strength 0.54
  8. Selwyn Maurice Vickers · 3 shared papers, 2018–2022 · strength 0.31
  9. Alice Nomura · 4 shared papers, 2017–2018 · strength 0.30
  10. Alexandra Naba · 1 shared paper, 2026 · strength 0.30
  11. James M. Considine · 1 shared paper, 2026 · strength 0.30
  12. Abhishek S. Kashyap · 1 shared paper, 2026 · strength 0.30
  13. Santanu Banerjee · 3 shared papers, 2018–2019 · strength 0.26
  14. Anthony R. Ferrantella · 2 shared papers, 2019–2020 · strength 0.19
  15. Julia Davydova · 1 shared paper, 2023 · strength 0.19
  16. Kazuho Inoko · 1 shared paper, 2023 · strength 0.19
  17. Shuhei Shinoda · 1 shared paper, 2023 · strength 0.19
  18. Mizuho Sato‐Dahlman · 1 shared paper, 2023 · strength 0.19
  19. Masato Yamamoto · 1 shared paper, 2023 · strength 0.19
  20. Vrishketan Sethi · 1 shared paper, 2022 · strength 0.15
  21. Somnath Pandey · 1 shared paper, 2022 · strength 0.15
  22. Shrey Modi · 1 shared paper, 2022 · strength 0.15
  23. Shweta Lavania · 1 shared paper, 2022 · strength 0.15
  24. Olivia McGinn · 2 shared papers, 2017 · strength 0.14
  25. Sai Sundeep Kollala · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.